Skip to content

Fungal mechanisms to escape the action of azole drugs and development of novel antifungal strategies

Specialized Group:

Fungal mechanisms to escape the action of azole drugs

and development of novel antifungal strategies

National Center of Microbiology. Carlos III Health Institute

Jorge Amich

 

From left to right: Samuel Cano Pascual, Ávaro González Camuesco, Rebecca Lobo Vega, Khalil Ashraph, Jorge Amich

 

Aspergillus fumigatus is a saprophytic filamentous fungus that in nature grows on decaying organic matter. However, through inhalation of airborne spores, this fungus can cause devastating chronic and invasive infections in the lungs of immunocompromised individuals and patients with underlying lung conditions (such as COPD or cystic fibrosis). These infections are termed aspergillosis and have very high associated mortality rates. The main reasons for mortality are the delicate status of patients (often immunosuppressed), the difficulty of reaching a precise diagnosis and the fact that there are only three classes of antifungal agents in clinical use to treat aspergilloses (azoles, echinocandins and polyenes). The azoles constitute the first line for treatment, but worryingly, azole resistance is now globally spread, which jeopardises our best therapeutic option. Indeed, infection with azole resistant isolates severely complicates patient management and increases mortality. Therefore, there is an urgent need to develop new antifungal strategies. Besides, mortality in patients that receive correct diagnosis and adequate azole therapy is still very high (~35% in invasive aspergillosis). The reasons are multifactorial, and we propose that azole persistence may be a relevant and underestimated cause of therapeutic failure.

RESEARCH ACTIVITY

In our group we develop three main research lines, all aimed to alleviate the burden of therapeutic failure.

  • Study of the phenomenon of azole persistence: genetic and molecular mechanisms, relevance in treatment failure and methods of detection.
    The phenomena of antimicrobial tolerance and persistence are gaining more and more attention. They define the capacity of certain strains of a pathogenic microbe to survive for extended periods in the presence of high concentrations of a cidal drug. In tolerance, all cells of the pathogen show this capacity of extended survival, whereas in persistence it is just a subpopulation of the cells. We were the first to describe that Aspergillus fumigatus can display persistence to azole antifungals, and we showed evidence to suggest that this might be relevant for clinical treatment.
    In our investigations on azole persistence, we have three overarching objectives. Firstly, we aim to establish methods to detect and investigate persistence in the laboratory, and methods to detect it in routine diagnosis. For this purpose, we are developing and validating both advanced microscopy-based analyses and straightforward phenotypic assays. Secondly, we have the goal of determining the relevance of azole persistence in treatment failure. To address this major objective, we are using animal models of infection and retrospective clinical analyses. Finally, we are working to unravel the genetic and molecular mechanisms of persistence. We are combining whole genome analysis, transcriptomics and molecular analyses to understand why some strains can display persistence, and also why only a subpopulation of the cells can survive the action of azoles.
  • Optimization and new developments for the detection of antifungal resistance and persistence.
    Precise diagnosis is crucial for the success of antifungal therapy. Indeed, it is imperative to detect infection with persister and resistant isolates, to guide and adequate antifungal therapy. In this sense, we are taking different approaches aimed to improve the diagnosis of resistance, like attempting to enhance the sensitivity of existing assays, developing new, faster assays and detecting it in samples where it is currently not possible. In addition, as mentioned above, we are developing methods to detect and measure antifungal persistence.
  • Differential modulation of fungal and host persulfidation as a novel antifungal strategy.
    Persulfidation is a post-translational modification that consists in the addition of a sulfide (S2-) to thiol groups (-SH) of cysteine residues in target proteins to form a persulfide group (-SSH). This modification has been shown to modulate the intrinsic activity of proteins, having a great impact on physiological and metabolic functions. We have shown that correct levels of persulfidation are required for both A. fumigatus pathogenic potential and the host immune antifungal response. In our current investigations we aim to differentially modulate the levels of persulfidation in the pathogen and the host cells to simultaneously reduce fungal virulence and potentiate the immune response. In addition, we are investigating how persulfidation influences the immune response, which can lead to the discovery of novel interventions to potentiate the antifungal response.

AFFILIATION

Reference and Research Laboratory in Mycology.
Centro Nacional de Microbiología.
Carlos III Health Institute
Madrid

CONTRIBUTIONS AND SELECTED PUBLICATIONS

  1. Peláez-García de la Rasilla T, Mato-López A, Pablos-Puertas, CE, González-Huerta AJ, Gómez-López A, Mellado E and Amich J. Potential Implication of Azole Persistence in the Treatment Failure of Two Haematological Patients Infected with Aspergillus fumigatus. J. Fungi. 2023, 9, 805. doi. 10.3390/jof9080805.
  2. Scott J, Valero C, Mato-López A, Donaldson IJ, Roldán A, Chown H, Van Rhijn N, Lobo-Vega R, Gago S, Furukawa T, Morogovsky A, Ben Ami R, Bowyer P, Osherov N, Fontaine T, Goldman GH, Mellado E, Bromley M, Amich J. Aspergillus fumigatus can display persistence to the fungicidal drug voriconazole. Microbiol. Spectr. 2023 Vol. 11, No. 2. doi: 10.1128/spectrum.04770-22.
  3. Sueiro-Olivares M, Scott J, Gago S, Petrovic, Kouroussis E, Zivanovic J, Yu Y, Strobel M, Cunha C, Thomson D, Fortune-Grant R, Thusek S, Bowyer P, Beilhack A, Carvalho A, Bignell E, Filipovic MR and Amich J. Fungal and host protein persulfidation are functionally correlated and modulate both virulence and antifungal response. PLos Biology. 2021 19 (6), e3001247. doi: 10.1371/journal.pbio.3001247.
  4. Scott J, Sueiro-Olivares M, Thornton BP, Owens RA, Muhamadali H, Fortune-Grant R, Thomson D, Thomas R, Hollywood K, Doyle S, Goodacre R, Tabernero L, Bignell E and Amich J. Targeting Methionine Synthase in a Fungal Pathogen Causes a Metabolic Imbalance That Impacts Cell Energetics, Growth, and Virulence. mBio. 2020 Oct 13;11(5):e01985-20. doi: 10.1128/mBio.01985-20
Play Video

Privacy Policy

This website is owned by the SPANISH SOCIETY OF MICROBIOLOGY, whose identification data are the following:

  • Center for Biological Research (CIB-CSIC)
  • c / Ramiro de Maeztu, 9 28040 Madrid.
  • Phone. 91 561 33 81 - Fax. 91 561 32 99
  • National Registry of Associations with the national number 579
  • CIF: G28648871

1. INFORMATION AND CONSENT.

By accepting this Privacy Policy, the User is informed and gives their free, informed, specific and unequivocal consent so that the personal data provided through this website (hereinafter, the "Website") are processed by SEM.

2. OBLIGATORY TO PROVIDE THE DATA.

The data requested in the web forms are generally mandatory (unless otherwise specified in the required field) to fulfill the established purposes. Therefore, if they are not provided or are not provided correctly, they will not be able to be attended to, without prejudice to the fact that you can freely view the content of the Website.

3. FOR WHAT PURPOSE WILL THE USER'S PERSONAL DATA BE PROCESSED AND FOR HOW LONG?

The personal data provided through the Website will be processed by SEM in accordance with the following purposes:

  • Manage and process the registration requests of new members, from the "new members" forms, as well as manage the fees and derived charges.
  • Periodically send members, including by electronic means, information, events or news that may be of interest to them, if the future member gives their consent by checking the corresponding check box, or, where appropriate, opposes or revokes their consent.

4. WHAT USER DATA WILL BE PROCESSED?

SEM will process the following categories of User data:

  • Identification data: name, surname and ID.
  • Contact information: postal address, email address and telephone.
  • Professional data: workplace and professional contact details.
  • Academic data: degree and specialization.
  • Billing information.

5. WHAT IS THE LEGITIMATION OF THE PROCESSING OF USER DATA?

The treatment of the User's data by the SEM is based on the consent that is requested and that you can withdraw at any time. However, in case of withdrawing your consent, this will not affect the legality of the treatments carried out previously.
The consents obtained for the aforementioned purposes are independent so that the User may revoke only one of them, not affecting the others.

6. TO WHICH RECIPIENTS WILL THE USER DATA BE COMMUNICATED?

The data of the partners may be communicated to the following companies in the cases indicated:

• To the corresponding banking entities in order to manage the collection of direct debit bills.

The User's data will not be communicated to any other entity, except legal obligation.

7. RESPONSIBILITY OF THE USER.

The User and the Candidate for membership:
- Guarantees that you are over 18 years of age and that the data you provide to the SEM is true, accurate, complete and updated. For these purposes, the User is responsible for the veracity of all the data that he communicates and will keep the information provided suitably updated, in such a way that it responds to his real situation.
- You will be responsible for the false or inaccurate information that you provide through the Website and for the direct or indirect damages that this causes to the SEM or to third parties.

8. COMMUNICATIONS.

One of the purposes for which the SEM processes the personal data provided by Users is to send them electronic communications with information related to congresses and other events, grant programs, scientific dissemination, awards or relevant news for the recipients.
In the event that the recipient wishes to stop receiving informative communications from the SEM, they can request the cancellation of the service by sending an email to secretaria.sem@semicrobiologia.com or by clicking on the "unsubscribe" link included in the communications.

9. EXERCISE OF RIGHTS.

The User can send a letter at any time and free of charge to the SEM, Centro de Investigaciones Biológicas (CIB-CSIC) - c / Ramiro de Maeztu, 9 28040 Madrid, attaching a photocopy of their identity document, to request their rights of access, rectification, deletion, opposition, limitation, portability of your data.
You can also complain to the Spanish Agency for Data Protection, through the following address: Spanish Agency for Data Protection, C / Jorge Juan, 6, 28001-Madrid, when the interested party considers that the SEM has violated the rights that They are recognized by the applicable regulations on data protection.

10. SECURITY MEASURES.

The SEM will treat the data of Users, Candidates and Partners at all times in an absolutely confidential manner and keeping the mandatory duty of secrecy regarding them, in accordance with the provisions of the applicable regulations, adopting technical measures and measures for this purpose. necessary organizational measures that guarantee the security of your data and prevent its alteration, loss, treatment or unauthorized access, taking into account the state of technology, the nature of the stored data and the risks to which they are exposed.

Solicitar inscripción en el curso Fungal mechanisms to escape the action of azole drugs and development of novel antifungal strategies